Bacteriology of sputum in cystic fibrosis: evaluation of dithiothreitol as a mucolytic agent
- PMID: 6776135
- PMCID: PMC273459
- DOI: 10.1128/jcm.11.6.552-557.1980
Bacteriology of sputum in cystic fibrosis: evaluation of dithiothreitol as a mucolytic agent
Abstract
Liquefaction and homogenization have been recommended to ensure accurate, representative sputum cultures. We evaluated dithiothreitol (DTT) as mucolytic agent for culturing sputum samples obtained from 79 cystic fibrosis (CF) patients. Liquefaction with DTT was not superior to direct plating of specimens for routine qualitative cultures. Unliquefied sputum cultures failed to direct 3 of 47 Pseudomonas aeruginosa isolates; DTT-treated specimens missed 5 of 13 Candida albicans isolates. Neither treated nor untreated sputum cultures were completely successful in detecting Staphylococcus aureus or Enterobacteriaceae. Since Haemophilus influenzae was recovered from only two qualitative cultures, we could not evaluate the effect of DTT on the receovery of this organism. However, 27 of 29 strains of H. influenzae were inhibited by concentrations of DTT near the recommended final working concentration of 50 micrograms/ml, suggesting that liquefaction might impair isolation of this organism. Liquefaction with DTT permitted quantitative cultures of CF sputum. The predominant pathogen in our CF population was P. aeruginosa; 37 of 43 (86%) patients were colonized with this organism. Median densities of rough and mucoid strains were 3.2 x 10(7) and 4.3 x 10(7) colony-forming units per ml, respectively. Previous oral antistaphylococcal therapy may have accounted for the observed low density of S. aureus (mean density, 3.5 x 10(3) colony-forming units per ml). We conclude that DTT treatment does not improve recovery of organisms from qualitative cultures but does facilitate quantitative studies of S. aureus and P. aeruginosa in CF sputum.
Similar articles
-
Qualitative and quantitative microbiological analysis of sputa of 102 patients with cystic fibrosis.Infection. 1987 Jul-Aug;15(4):270-7. doi: 10.1007/BF01644137. Infection. 1987. PMID: 3117700
-
Selective media for the quantitation of bacteria in cystic fibrosis sputum.J Med Microbiol. 1984 Apr;17(2):113-9. doi: 10.1099/00222615-17-2-113. J Med Microbiol. 1984. PMID: 6423825
-
Long-term, low-dose azithromycin treatment reduces the incidence but increases macrolide resistance in Staphylococcus aureus in Danish CF patients.J Cyst Fibros. 2009 Jan;8(1):58-62. doi: 10.1016/j.jcf.2008.09.001. Epub 2008 Oct 11. J Cyst Fibros. 2009. PMID: 18849202
-
[Physiopathology of cystic fibrosis and of infections associated to this disease].Pneumologia. 2007 Oct-Dec;56(4):202-7. Pneumologia. 2007. PMID: 18320796 Review. Romanian.
-
Antibiotic use in cystic fibrosis.Drug Intell Clin Pharm. 1984 Oct;18(10):772-83. doi: 10.1177/106002808401801001. Drug Intell Clin Pharm. 1984. PMID: 6435985 Review.
Cited by
-
Occurrence of hypermutable Pseudomonas aeruginosa in cystic fibrosis patients is associated with the oxidative stress caused by chronic lung inflammation.Antimicrob Agents Chemother. 2005 Jun;49(6):2276-82. doi: 10.1128/AAC.49.6.2276-2282.2005. Antimicrob Agents Chemother. 2005. PMID: 15917521 Free PMC article.
-
Simple method for quantifying viable bacterial numbers in sputum.J Clin Pathol. 1995 Aug;48(8):719-24. doi: 10.1136/jcp.48.8.719. J Clin Pathol. 1995. PMID: 7560197 Free PMC article.
-
Qualitative and quantitative microbiological analysis of sputa of 102 patients with cystic fibrosis.Infection. 1987 Jul-Aug;15(4):270-7. doi: 10.1007/BF01644137. Infection. 1987. PMID: 3117700
-
Selective pressure of antistaphylococcal chemotherapeutics in favour of Pseudomonas aeruginosa in cystic fibrosis.Infection. 1987 Nov-Dec;15(6):469-70. doi: 10.1007/BF01647240. Infection. 1987. PMID: 3125114
-
Phase I Studies of Acebilustat: Biomarker Response and Safety in Patients with Cystic Fibrosis.Clin Transl Sci. 2017 Jan;10(1):28-34. doi: 10.1111/cts.12428. Epub 2016 Nov 2. Clin Transl Sci. 2017. PMID: 27806191 Free PMC article. Clinical Trial.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical